These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. Wong CS; Jelacic S; Habeeb RL; Watkins SL; Tarr PI N Engl J Med; 2000 Jun; 342(26):1930-6. PubMed ID: 10874060 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial and antimotility agent use in persons with shiga toxin-producing Escherichia coli O157 infection in FoodNet Sites. Nelson JM; Griffin PM; Jones TF; Smith KE; Scallan E Clin Infect Dis; 2011 May; 52(9):1130-2. PubMed ID: 21467017 [TBL] [Abstract][Full Text] [Related]
12. Can we predict the development of haemolytic uraemic syndrome in the early stage of Escherichia coli O157 infection? Joishy M; Jauhari P; Mathew AA; Rangarajan T Arch Dis Child; 2008 Feb; 93(2):180-1. PubMed ID: 18208996 [No Abstract] [Full Text] [Related]